Ben Snedeker
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
Ben Snedeker is a Partner and Head of Public Equities at Catalio Capital Management, where he manages the firm’s public equities portfolio and also serves as Co-Head of Investments and a member of the Management Committee. At Catalio, his work focuses on investment opportunities across innovative healthcare companies and across the life sciences capital structure. Before joining Catalio, he was Sector Head Therapeutics at HealthCor Management and PointState Capital. Earlier in his career, he was a therapeutics analyst and portfolio manager at D.E. Shaw & Co. and an Associate Principal at McKinsey & Company in its Global Pharmaceuticals and Medical Products practice, where he also co-founded McKinsey’s Philadelphia office.
Updated 16 September 2026
Public sources: cataliocapital.com
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Ben Snedeker appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data